SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-070403
Filing Date
2023-12-14
Accepted
2023-12-14 16:20:08
Documents
15
Period of Report
2023-12-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hsto-20231214.htm   iXBRL 8-K 62508
2 EX-99.1 hsto-ex99_1.htm EX-99.1 19830
3 GRAPHIC img196544735_0.jpg GRAPHIC 2092
4 GRAPHIC img196544735_1.jpg GRAPHIC 388989
  Complete submission text file 0000950170-23-070403.txt   750587

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT hsto-20231214.xsd EX-101.SCH 2474
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT hsto-20231214_pre.xml EX-101.PRE 11118
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT hsto-20231214_lab.xml EX-101.LAB 17945
9 EXTRACTED XBRL INSTANCE DOCUMENT hsto-20231214_htm.xml XML 4527
Mailing Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121
Business Address 10655 SORRENTO VALLEY ROAD SUITE 200 San Diego CA 92121 (858) 526-3100
Histogen Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 231487315
SIC: 2834 Pharmaceutical Preparations